GoodRx Holdings (GDRX) Net Cash Flow (2019 - 2026)
GoodRx Holdings' Net Cash Flow history spans 7 years, with the latest figure at -$11.7 million for Q4 2025.
- On a quarterly basis, Net Cash Flow fell 147.66% to -$11.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$186.5 million, a 16.71% increase, with the full-year FY2025 number at -$186.5 million, up 16.71% from a year prior.
- Net Cash Flow hit -$11.7 million in Q4 2025 for GoodRx Holdings, down from -$7.8 million in the prior quarter.
- Over the last five years, Net Cash Flow for GDRX hit a ceiling of $32.9 million in Q3 2023 and a floor of -$147.4 million in Q1 2025.
- Historically, Net Cash Flow has averaged -$35.5 million across 5 years, with a median of -$8.1 million in 2024.
- Biggest five-year swings in Net Cash Flow: soared 1976.68% in 2023 and later crashed 3655.01% in 2024.
- Tracing GDRX's Net Cash Flow over 5 years: stood at $29.1 million in 2021, then fell by 2.43% to $28.4 million in 2022, then crashed by 532.04% to -$122.6 million in 2023, then soared by 120.04% to $24.6 million in 2024, then crashed by 147.66% to -$11.7 million in 2025.
- Business Quant data shows Net Cash Flow for GDRX at -$11.7 million in Q4 2025, -$7.8 million in Q3 2025, and -$19.7 million in Q2 2025.